Edition:
United States

Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

7.12USD
20 Apr 2018
Change (% chg)

$-0.04 (-0.56%)
Prev Close
$7.16
Open
$7.12
Day's High
$7.16
Day's Low
$7.03
Volume
28,854
Avg. Vol
86,392
52-wk High
$11.91
52-wk Low
$6.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 34.75 -0.299
Sep '17 39.67 0.524
Jun '17 46.31 0.681
Mar '17 52.51 0.605
FY 2016 Dec '16 43.08 0.115
Sep '16 32.09 -0.485
Jun '16 38.86 -0.484
Mar '16 36.22 -0.147
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 27.32 28.74 25.90 --
Quarter Ending Sep-18 2 27.05 29.31 24.80 --
Year Ending Dec-18 4 108.77 118.70 104.00 157.98
Year Ending Dec-19 2 144.58 153.48 135.68 151.38
Earnings (per share)
Quarter Ending Jun-18 2 -0.40 -0.30 -0.49 --
Quarter Ending Sep-18 2 -0.40 -0.31 -0.49 --
Year Ending Dec-18 3 -1.37 -1.02 -1.87 0.20
Year Ending Dec-19 2 -0.06 -0.03 -0.09 0.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 4.71 188.22 33.60
P/E High - Last 5 Yrs. 12.72 284.72 45.95
P/E Low - Last 5 Yrs. 5.29 95.76 24.93
Beta 1.52 0.75 0.80
Price to Sales (TTM) 1.56 136.15 7.07
Price to Book (MRQ) 3.27 19.54 5.13
Price to Tangible Book (MRQ) -- 24.07 6.73
Price to Cash Flow (TTM) 3.88 122.99 25.52
% Owned Institutions 77.26 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) 0.00 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -19.34 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago 15.31 79.72 10.83
Sales - 5 Yr. Growth Rate 87.21 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -360.54 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago 251.02 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate 118.88 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.36 1.63 2.53
Current Ratio (MRQ) 1.43 5.97 3.62
LT Debt to Equity (MRQ) 86.56 23.32 11.31
Total Debt to Equity (MRQ) 86.68 25.75 13.97
Interest Coverage (TTM) 9.32 -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 90.59 36.56 54.01
Gross Margin - 5 Yr. Avg. 91.29 55.38 52.12
EBITD Margin (TTM) 38.03 -- --
EBITD - 5 Yr. Avg 38.40 -152.18 15.89
Operating Margin (TTM) 51.66 -563.03 4.33
Operating Margin - 5 Yr. Avg. 1.54 -164.18 11.25
Pre-Tax Margin (TTM) 53.48 -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. 2.48 -171.12 11.56
Net Profit Margin (TTM) 37.38 -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -13.71 -171.01 7.89
Effective Tax Rate (TTM) 30.11 -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. 654.07 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,025,118 23,887,722 816,988,634
Net Income/Employee (TTM) 383,183 956,935 96,050,323
Receivable Turnover (TTM) 10.62 6.24 5.56
Inventory Turnover (TTM) 3.46 2.37 3.45
Asset Turnover (TTM) 0.69 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 25.97 -0.77 10.54
Return on Assets - 5 Yr. Avg. -7.55 0.70 11.56
Return on Investment (TTM) 37.03 -0.74 13.19
Return on Investment - 5 Yr. Avg. -10.61 4.20 14.97
Return on Equity (TTM) 101.46 -2.80 15.00
Return on Equity - 5 Yr. Avg. -38.30 -0.05 16.25
  1 Year 3 Year 5 Year
Sales % 15.31 126.17 87.21
EPS (TTM) % 254.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avadel Pharmaceuticals PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.26%
# of Holders: 107
Total Shares Held: 29,321,273
3 Mo. Net Change: 1,344,388
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 5
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.